To what extent will health clinics go to keep selling in-demand weight-loss drugs now that the FDA has outlawed cheaper ...

Vivani Medical, Inc. (VANI), on Wednesday, announced promising preclinical data for its semaglutide implant in development ...

While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...

Eli Lilly says Indianapolis-based Premier Weight Loss is cracking open auto-injector pens containing its blockbuster drug and ...

Compounded versions could make up as much as 40% of the semaglutide market, said Novo Nordisk CEO Lars Fruergaard Jorgensen ...

Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent ...

The new Black-owned B Beautiful Medical Spa, led by CEO Briana Kelly, offers a luxury experience with her services.

NanoPortal™ technology successfully delivers semaglutide, the active ingredient in Ozempic®/Wegovy®, in a preclinical study ...

A groundbreaking study from the University of British Columbia has revealed a potentially disturbing side effect for those taking popular weight loss medications containing semaglutide ...

Semaglutide ... reach their target weight. The study did have some limitations, noted researcher Etminan. Those included the fact that it could not verify hair loss through medical records ...

March 26, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ ... its subdermal semaglutide implant under development for chronic weight management in obese and overweight individuals.